Details of the Drug
General Information of Drug (ID: DM8IHQP)
Drug Name |
N-methyl-3,3-diphenylpropan-1-amine
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
N-Methyl-3,3-diphenylpropylamine; 28075-29-8; N-methyl-3,3-diphenylpropan-1-amine; W-107076; EINECS 248-821-5; n-methyl-3,3-diphenylpropan-1-amin; Diphenylpropyl-methylamin; AC1L3PJ5; AC1Q1HZ6; diphenylalkylamine (DPA), 5b; CHEMBL593494; SCHEMBL3638413; Jsp005413; Methyl(3,3-diphenylpropyl)amine; BDBM35933; CTK4G0777; (3,3-Diphenylpropyl)methylamine; DTXSID00182350; AKEGHAUFMKCWGX-UHFFFAOYSA-N; 3,3-Diphenyl-N-methylpropylamine; MolPort-003-737-089; ZINC5996308; ACT07251; Benzenepropanamine,N-methyl-g-phenyl-
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 225.33 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 3.6 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 5 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 1 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
|||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||